SDSarthak Das

Sarthak Das

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sarthak Das has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Metabolic Syndrome Among Overweight and Obese Children Visiting Tertiary Care Hospital of Jharkhand: A Cross-Sectional Study

    by Mandeep Kaur, Sarthak Das, Vinayagamoorthy Venugopal, Saroj K Tripathy, Ehtesham Ansari, Soumi Kundu, Archana Malik

    Background: Childhood obesity is a growing public health challenge and is closely linked to metabolic syndrome, a cluster of cardiometabolic abnormalities that predispose to type 2 diabetes and cardiovascular disease. Data on the prevalence and determinants of metabolic syndrome among Indian children, particularly in underserved regions, remain limited. Objective: The aim of the study is to estimate the prevalence and predictors of metabolic syndrome among overweight and obese children attending a tertiary care hospital in Jharkhand, India. Methods: A hospital-based cross-sectional study was conducted between January 2024 and March 2025 among 250 overweight and obese children aged 5-15 years at AIIMS Deoghar. Anthropometric measures, blood pressure, and fasting biochemical parameters (glucose, triglycerides, high-density lipoprotein, low-density lipoprotein, and total cholesterol) were assessed. Metabolic syndrome was defined using the Indian Academy of Pediatrics (IAP) criteria. Statistical analyses included chi-square tests, t-tests, and logistic regression to determine independent predictors. Results: The prevalence of metabolic syndrome was 38% (n=95; 95% CI: 31.9-44.1). Significant risk factors included family history of obesity (OR: 1.7, 95% CI: 1.22-2.48), excess junk food intake (OR: 1.58, 95% CI: 1.18-2.11), abnormal developmental history (OR: 2.07, 95% CI: 1.39-3.08), low physical activity (2 hours/day (OR: 1.44, 95% CI: 1.01-2.07), and birth weight <2.5 kg (adjusted OR: 1.43, 95% CI: 1.09-1.88). Protective factors included exclusive breastfeeding for six months (p<0.001). No significant association was observed with gender or parental education. Conclusion: Metabolic syndrome is highly prevalent among overweight and obese children in Jharkhand, with both lifestyle-related (diet, physical activity, and screen time) and perinatal (low birth weight and maternal diabetes/hypertension) factors contributing. Early interventions targeting modifiable risk factors through lifestyle modification and health education are essential to reduce long-term cardiometabolic risks in this population.

  • Protecting future generations from E-waste: Policy gaps and WHO's call to action

    by Sarthak Das, Saroj Kumar Tripathy, Archana Malik

    The rapid expansion of digital technology has revolutionized education, communication and healthcare but created a parallel crisis: e-waste. Globally, 53.6 million tonnes were generated in 2019, with only 17.4% formally recycled. The remainder is processed through unsafe methods such as open burning, acid leaching and crude dismantling. Children and pregnant women are especially vulnerable due to rapid growth, immature organs and special circumstances. India is the world's third-largest e-waste generator, producing 1.71 million tonnes annually, 1 while WHO estimates report 3230 kilotons in 2019. 1 Over 90% is handled informally, often involving child labour or exposure in contaminated communities. Documented childhood injury includes impaired neurodevelopment, poor birth outcomes, respiratory illness, endocrine disruption, immune dysfunction, DNA damage and higher lifetime risk of chronic diseases. Despite E-Waste Management Rules, awareness among paediatricians, policymakers and parents remains limited. Urgent measures include training, biomonitoring, prohibition of child labour and integration of e-waste risks into national child health programmes. Protecting children from e-waste is both a health necessity and a developmental imperative aligned with many local Sustainable Development Goals.

  • AHA/AAP 2025 neonatal resuscitation guideline update: Key changes and practice implications for pediatricians

    by Saroj Kumar Tripathy, Sarthak Das

    The 2025 neonatal resuscitation guidelines, developed jointly by the American Heart Association and the American Academy of Pediatrics, provide evidence-based recommendations for the most crucial actions during delivery and throughout the neonatal period. Ventilation remains the cornerstone of resuscitation, starting with ventilation rates of 30–60/ min, ≥ 30% oxygen for very preterm infants (<32 weeks), guided by pulse oximetry and electrocardiography monitoring to avoid hyperoxia. Deferred cord clamping (≥60 sec), strict thermal regulation and skin-to-skin contact are strongly encouraged. Laryngeal mask airways can be used as an alternate device in failed bag-mask ventilation in term infants. The 2025 guidelines shift neonatal resuscitation from an algorithmic event to a continuum of care, emphasizing system readiness, team integration, precise physiological targets and structured recovery – while maintaining core resuscitation principles established in 2015.

  • Management of Sepsis and Septic Shock in Children: Surviving Sepsis Campaign International Guidelines 2026

    by Saroj Kumar Tripathy, Sarthak Das, Md Ehtesham Ansari

    Sepsis is one of the leading causes of mortality and morbidity in children. The pediatric-specific Surviving Sepsis Campaign (SSC) guidelines 2026 introduce probable sepsis, suspected septic shock, and septic shock with persistent hypoperfusion to practically involve all children, aged ≥ 37 weeks at birth to 18 years, with acute infection and organ dysfunction. Key changes in these guidelines include measuring blood lactate at initial assessment, early antimicrobial therapy, implementation of performance improvement programs in hospitals, and the use of cardiac and lung point-of-care ultrasound (POCUS), a conservative oxygen strategy (SpO₂ target 88-92%), and early rehabilitation. The 2026 update highlights flexibility, early recognition, cautious intervention, and long-term recovery, while recognizing considerable gaps in evidence that warrant further research.

  • Updates in paediatric advanced life support (PALS) 2025: Implications for clinical practice

    by Saroj Kumar Tripathy, Sarthak Das, Ehtesham Ansari

    The 2025 pediatric advanced life support guidelines, developed by the American Heart Association and the American Academy of Pediatrics, are a resource for healthcare professionals caring for infants and children under 18 years of age in peri-arrest and other emergency care situations. The new guidelines address evolving pediatric cardiac arrest patterns, characterized predominantly by respiratory failure or shock, with persistent disparities in out-of-hospital survival and neurological outcomes. Major revisions include setting a blood pressure target above the 10 th centile post-cardiac arrest, administering epinephrine after two attempts of defibrillation in a shockable rhythm, and administering early epinephrine in non-shockable cardiac arrest, as well as preventing hyperthermia. It also emphasizes evidence-based strategies such as early high-quality cardiopulmonary resuscitation (CPR), targeted post-arrest care, continuous electroencephalogram for neurological monitoring, and IV sotalol as an option for refractory supraventricular tachycardia. Long-term survivor support and family presence during resuscitation are integrated as vital aspects of care. While core recommendations-such as CPR technique, ventilation strategies, and shock management-are reaffirmed, the update provides a robust framework for multicentric harmonization. The adoption of these updated protocols in promises enhanced resuscitation outcomes, consistent neurological recovery, and the development of context-specific best practices in pediatric emergency care.

  • Open Access

    Clinical Profile and Hematologic Parameters of Children Under Five Years Presenting With Wheeze

    by Saroj K Tripathy, Medhagopal R. G., Sarthak Das, Archana Malik

  • WHO Recommendations on Adolescent Pregnancy Prevention and Improving Pregnancy Outcomes: A Call for Action in Indian Settings

    by Swati Priya, Saroj Kumar Tripathy, Sarthak Das

    Adolescent pregnancy is a significant public health issue, especially in low- and middle-income countries (LMICs). According to recent estimates, about 21 million girls aged 15–19 in developing regions become pregnant each year, with roughly 50% of these pregnancies being unintended. It has serious health, social, and economic effects, making it essential to address the root causes and impacts of adolescent pregnancy. Herein, we provide a brief overview of the scope of the problem, the context in which teenage pregnancies occur, and the global response to this critical issue. In the Indian context, the call for action requires strengthening legal frameworks against child marriage, expansion of comprehensive sexuality education (CSE), and scale-up of adolescent-friendly health services.


  • Open Access

    Acetazolamide-Assisted Weaning From Mechanical Ventilation in a Child With Mixed Sleep Apnea: A Case Report

    by Saroj Kumar Tripathy, Sarbari Sarkar, Medhagopal R. G., Pradosh Kumar Sarangi, Archana Malik, Sarthak Das

    An elevated central apnea-hypopnea index is typically considered indicative of abnormal breathing in children. Treatment of central sleep apnea (CSA) is complex, and multiple treatment options are tried with variable outcomes. Acetazolamide, a carbonic anhydrase inhibitor, is known to induce metabolic acidosis and can stimulate the respiratory drive. We report a 13-year-old boy who was having obesity and mixed apnea with an apnea-hypopnea index of 67.4/hour, who was hospitalized with hypercapnic respiratory failure. He was successfully weaned from prolonged mechanical ventilation following acetazolamide therapy. Post-discharge, he has had no apnea and continues to do well, with an improved quality of life at two months of follow-up. Acetazolamide use for central apnea/mixed apnea in children is very rare and not well established. Our case highlights the potential use of acetazolamide as an adjunct therapy in children with CSA, which needs further exploration.

  • Open Access

    Beyond anticholinergic effects: A case of trihexyphenidyl-induced bradycardia

    by Soumi Kundu, R. G. Medhagopal, Sarthak Das, Saroj K. Tripathy, Sarbari Sarkar, E. Ansari, Archana Malik

    Anticholinergic drugs are extensively employed in clinical settings, with their side effects well-documented. However, paradoxical bradycardia due to trihexyphenidyl hydrochloride, an anticholinergic agent, is an infrequent and underreported phenomenon. This may be attributed to a lack of vigilant monitoring in patients undergoing therapy. Here, we present the case of a 12-year-old girl who developed sinus bradycardia following the administration of trihexyphenidyl. The heart rate normalized upon drug discontinuation. This report emphasizes the need for thorough cardiac monitoring, including baseline heart rate, Electrocardiogram (ECG), and electrolyte evaluation, before initiating therapy to prevent adverse outcomes.